- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
7
7 companies
Consun Pharmaceutical Group
Market Cap: HK$10.5b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$12.70
7D
-3.8%
1Y
13.6%
CanSino Biologics
Market Cap: HK$9.6b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$21.96
7D
-1.8%
1Y
-38.4%
InnoCare Pharma
Market Cap: HK$23.0b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.74
7D
3.8%
1Y
-21.9%
China Medical System Holdings
Market Cap: HK$24.6b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$10.15
7D
-1.6%
1Y
-15.4%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.3b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.42
7D
-17.4%
1Y
14.2%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.87
7D
-20.1%
1Y
-38.9%
Pak Fah Yeow International
Market Cap: HK$738.6m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.40
7D
-1.2%
1Y
-4.0%